#Harvoni

The high cost of hepatitis C treatment in the U.S. is about to see a major shift to lower prices of the major leading hepatitis C treatments

The drugs are set to come out in January 2019 with a list price of $24,000 for the most common dose for each.

Hepatitis C Patient John, shares his conquering story from hep C, end stage liver disease, liver cancer and liver transplantation.

Part 2 of Connie Welch’s interview with John M, a patient with hepatitis C and cirrhosis, who was successfully treated with Harvoni.

Nevertheless, researchers advise careful kidney monitoring when pairing the medications.

Connie Welch’s interview of John M, who was successfully treated and cured from hepatitis C in 2014 with Harvoni.

This is according to an analysis of a large group of veterans.

With many hepatitis C treatments on the market today, patients may ask which hepatitis C treatment is right for me? What’s the difference?

In a recent study of more than 600 HIV-positive adults, 93 percent were cured of hep C.

A brief look at current data on hepatitis C treatment response rates in Blacks using the newest direct-acting antivirals.

A recent study of Dutch clinicians found that they generally did a good job of preventing drug-drug interactions.

Ending the epidemic is going to require addressing the fact that certain individuals are at high risk of reinfection after a cure.

National guidelines have indicated that Blacks who qualify for the eight-week hep C treatment should nevertheless take 12 weeks.

Among a large group treated with minimal or no liver fibrosis, liver-health problems were almost nonexistent up to three years later.